Boston Scientific (BSX) Competitors

$74.65
+0.10 (+0.13%)
(As of 05/17/2024 ET)

BSX vs. SYK, BDX, DXCM, RMD, REGN, VRTX, MDT, CI, GSK, and ELV

Should you be buying Boston Scientific stock or one of its competitors? The main competitors of Boston Scientific include Stryker (SYK), Becton, Dickinson and Company (BDX), DexCom (DXCM), ResMed (RMD), Regeneron Pharmaceuticals (REGN), Vertex Pharmaceuticals (VRTX), Medtronic (MDT), The Cigna Group (CI), GSK (GSK), and Elevance Health (ELV). These companies are all part of the "medical" sector.

Boston Scientific vs.

Stryker (NYSE:SYK) and Boston Scientific (NYSE:BSX) are both large-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, media sentiment, risk, valuation, community ranking and earnings.

Stryker currently has a consensus target price of $365.94, suggesting a potential upside of 9.34%. Boston Scientific has a consensus target price of $75.32, suggesting a potential upside of 0.90%. Given Boston Scientific's higher possible upside, analysts clearly believe Stryker is more favorable than Boston Scientific.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Stryker
0 Sell rating(s)
4 Hold rating(s)
14 Buy rating(s)
0 Strong Buy rating(s)
2.78
Boston Scientific
0 Sell rating(s)
2 Hold rating(s)
18 Buy rating(s)
1 Strong Buy rating(s)
2.95

Stryker has a beta of 0.91, meaning that its stock price is 9% less volatile than the S&P 500. Comparatively, Boston Scientific has a beta of 0.77, meaning that its stock price is 23% less volatile than the S&P 500.

77.1% of Stryker shares are held by institutional investors. Comparatively, 89.1% of Boston Scientific shares are held by institutional investors. 5.9% of Stryker shares are held by company insiders. Comparatively, 0.5% of Boston Scientific shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

In the previous week, Boston Scientific had 13 more articles in the media than Stryker. MarketBeat recorded 22 mentions for Boston Scientific and 9 mentions for Stryker. Boston Scientific's average media sentiment score of 0.70 beat Stryker's score of 0.59 indicating that Stryker is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Stryker
7 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Boston Scientific
7 Very Positive mention(s)
3 Positive mention(s)
9 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Stryker has a net margin of 16.03% compared to Stryker's net margin of 12.06%. Boston Scientific's return on equity of 23.05% beat Stryker's return on equity.

Company Net Margins Return on Equity Return on Assets
Stryker16.03% 23.05% 10.88%
Boston Scientific 12.06%16.39%9.08%

Boston Scientific received 108 more outperform votes than Stryker when rated by MarketBeat users. Likewise, 69.33% of users gave Boston Scientific an outperform vote while only 64.51% of users gave Stryker an outperform vote.

CompanyUnderperformOutperform
StrykerOutperform Votes
889
64.51%
Underperform Votes
489
35.49%
Boston ScientificOutperform Votes
997
69.33%
Underperform Votes
441
30.67%

Stryker has higher revenue and earnings than Boston Scientific. Stryker is trading at a lower price-to-earnings ratio than Boston Scientific, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Stryker$20.50B6.22$3.17B$8.7638.21
Boston Scientific$14.71B7.45$1.59B$1.1962.73

Summary

Stryker beats Boston Scientific on 10 of the 19 factors compared between the two stocks.

Get Boston Scientific News Delivered to You Automatically

Sign up to receive the latest news and ratings for BSX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BSX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BSX vs. The Competition

MetricBoston ScientificSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$109.52B$4.09B$5.32B$18.14B
Dividend YieldN/A2.02%44.08%3.44%
P/E Ratio62.7315.08137.8025.10
Price / Sales7.4567.312,351.8311.30
Price / Cash25.6848.1636.8119.46
Price / Book5.434.935.746.01
Net Income$1.59B$5.71M$108.91M$966.65M
7 Day Performance1.30%2.10%1.42%1.85%
1 Month Performance10.87%4.26%4.95%6.59%
1 Year Performance39.17%17.72%7.81%23.69%

Boston Scientific Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SYK
Stryker
4.8673 of 5 stars
$324.30
-0.1%
$365.94
+12.8%
+17.3%$123.54B$20.50B37.0252,000
BDX
Becton, Dickinson and Company
4.9296 of 5 stars
$235.00
-0.8%
$281.40
+19.7%
-6.1%$67.92B$19.37B51.7673,000Insider Selling
Short Interest ↓
News Coverage
DXCM
DexCom
4.8525 of 5 stars
$125.97
+0.8%
$141.67
+12.5%
+10.4%$50.10B$3.62B81.279,600Analyst Upgrade
Short Interest ↓
Positive News
RMD
ResMed
4.6519 of 5 stars
$215.85
-0.9%
$202.80
-6.0%
-2.5%$31.71B$4.22B33.1610,140
REGN
Regeneron Pharmaceuticals
4.0614 of 5 stars
$984.64
+0.8%
$981.71
-0.3%
+31.4%$108.50B$13.12B29.0913,450Analyst Forecast
Insider Selling
News Coverage
VRTX
Vertex Pharmaceuticals
4.1627 of 5 stars
$428.59
-0.3%
$432.18
+0.8%
+31.2%$110.60B$9.87B27.815,400Analyst Upgrade
MDT
Medtronic
4.5677 of 5 stars
$84.29
+0.9%
$94.91
+12.6%
-3.5%$111.92B$31.23B26.8495,000Upcoming Earnings
News Coverage
CI
The Cigna Group
4.8197 of 5 stars
$346.17
-0.9%
$366.14
+5.8%
+32.1%$98.34B$195.27B28.4272,500Insider Selling
Short Interest ↓
GSK
GSK
2.3178 of 5 stars
$45.66
+1.1%
N/A+27.7%$94.63B$30.74B16.5470,200News Coverage
ELV
Elevance Health
3.9177 of 5 stars
$534.63
-0.8%
$587.42
+9.9%
+20.4%$124.26B$171.34B20.21104,900Short Interest ↑
Positive News

Related Companies and Tools

This page (NYSE:BSX) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners